Michael J. Pishvaian
- Oncology top 0.5%
- Molecular Biology top 5%
- Cancer Research top 1%
- Pulmonary and Respiratory Medicine top 2%
- Immunology top 5%
- Co-authors
- Jonathan R. BrodyJohn L. MarshallStephen W. ByersAline CharabatyAiwu Ruth HeJimmy J. HwangJoanne XiuSubha Madhavan
- Topics
- Pancreatic and Hepatic Oncology Research (100 papers)Cancer Genomics and Diagnostics (62 papers)Colorectal Cancer Treatments and Studies (34 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Journal of Biological ChemistryJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Michael J. Pishvaian
200 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 3.8k
- Molecular Biology 1.9k
- Cancer Research 1.5k
- Pulmonary and Respiratory Medicine 1.1k
- Immunology 831
Countries citing papers authored by Michael J. Pishvaian
This map shows the geographic impact of Michael J. Pishvaian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Pishvaian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Pishvaian more than expected).
Fields of papers citing papers by Michael J. Pishvaian
This network shows the impact of papers produced by Michael J. Pishvaian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Pishvaian. The network helps show where Michael J. Pishvaian may publish in the future.
Co-authorship network of co-authors of Michael J. Pishvaian
This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Pishvaian. A scholar is included among the top collaborators of Michael J. Pishvaian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Pishvaian. Michael J. Pishvaian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 22 | |
| 6 | 12 | |
| 7 | 32 | |
| 8 | 44 | |
| 9 | 4 | |
| 10 | 181 | |
| 11 | 149 | |
| 12 | 2 | |
| 13 | 25 | |
| 14 | 171 | |
| 15 | Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Studybreakdown → | 377 |
| 16 | 64 | |
| 17 | 9 | |
| 18 | 7 | |
| 19 | 80 | |
| 20 | CDK4 is an important target for hepatocellular cancer with inactivation of TGF-beta signaling through Smad and ELF | 2 |
About Michael J. Pishvaian
Michael J. Pishvaian is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 216 papers that have together received 5.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (100 papers), Cancer Genomics and Diagnostics (62 papers) and Colorectal Cancer Treatments and Studies (34 papers). The work is most often cited by research in Oncology (3.8k citations), Cancer Research (1.5k citations) and Immunology (831 citations). Michael J. Pishvaian has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Jonathan R. Brody, John L. Marshall, Stephen W. Byers, Aline Charabaty, Aiwu Ruth He, Jimmy J. Hwang, Joanne Xiu, Subha Madhavan, Andrew Hendifar and Patrick A. Ott. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.